Amphastar Pharmaceuticals, Inc.
2018 Q3 - 2025 Q4 (30 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 564 | 0.0% | 21,075 | 12/31/2025 |
| 2025 Q3 | 11/13/2025 | 615 | 0.0% | 23,093 | 9/30/2025 |
| 2025 Q2 | 8/13/2025 | 530 | 0.0% | 23,093 | 6/30/2025 |
| 2025 Q1 | 5/14/2025 | 669 | 0.0% | 23,093 | 3/31/2025 |
| 2024 Q4 | 2/13/2025 | 871 | 0.0% | 23,452 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 1,097 | 0.0% | 22,607 | 9/30/2024 |
| 2024 Q2 | 8/13/2024 | 904 | 0.0% | 22,607 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 857 | 0.0% | 19,517 | 3/31/2024 |
| 2023 Q4 | 4/22/2024 | 1,266 | 0.0% | 20,467 | 12/31/2023 |
| 2023 Q3 | 5/9/2024 | 941 | 0.0% | 20,467 | 9/30/2023 |
| 2023 Q2 | 4/29/2024 | 1,176 | 0.0% | 20,467 | 6/30/2023 |
| 2023 Q1 | 5/9/2024 | 768 | 0.0% | 20,467 | 3/31/2023 |
| 2022 Q4 | 5/10/2024 | 573 | 0.0% | 20,467 | 12/31/2022 |
| 2022 Q3 | 5/10/2024 | 575 | 0.0% | 20,467 | 9/30/2022 |
| 2022 Q2 | 5/10/2024 | 712 | 0.0% | 20,467 | 6/30/2022 |
| 2022 Q1 | 5/10/2024 | 735 | 0.0% | 20,467 | 3/31/2022 |
| 2021 Q4 | 5/17/2024 | 275 | 0.0% | 11,803 | 12/31/2021 |
| 2021 Q3 | 5/17/2024 | 224 | 0.0% | 11,803 | 9/30/2021 |
| 2021 Q2 | 5/17/2024 | 238 | 0.0% | 11,803 | 6/30/2021 |
| 2021 Q1 | 5/17/2024 | 216 | 0.0% | 11,803 | 3/31/2021 |
| 2020 Q4 | 5/24/2024 | 366 | 0.0% | 18,205 | 12/31/2020 |
| 2020 Q3 | 5/24/2024 | 341 | 0.0% | 18,205 | 9/30/2020 |
| 2020 Q2 | 5/24/2024 | 409 | 0.0% | 18,205 | 6/30/2020 |
| 2020 Q1 | 7/12/2023 | 270 | 0.0% | 18,205 | 3/31/2020 |
| 2019 Q4 | 7/12/2023 | 351 | 0.0% | 18,205 | 12/31/2019 |
| 2019 Q3 | 7/12/2023 | 361 | 0.0% | 18,205 | 9/30/2019 |
| 2019 Q2 | 7/12/2023 | 384 | 0.0% | 18,205 | 6/30/2019 |
| 2019 Q1 | 7/13/2023 | 372 | 0.0% | 18,205 | 3/31/2019 |
| 2018 Q4 | 7/13/2023 | 362 | 0.0% | 18,205 | 12/31/2018 |
| 2018 Q3 | 7/13/2023 | 350 | 0.0% | 18,205 | 9/30/2018 |